Generate Biomedicines, Inc. (GENB)

NASDAQ: GENB · Real-Time Price · USD

16.52

-0.94 (-5.38%)

At close: Sep 23, 2026, 4:00 PM EDT

16.55

+0.03 (0.18%)

After-hours: Sep 23, 2026, 7:58 PM EDT

Generate Biomedicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	135.36	121.65	176.27
Short-Term Investments	322.06	99.85	217.36
Cash & Short-Term Investments	457.42	221.5	393.63
Cash Growth	-	-43.73%	-
Receivables	-	-	0.31
Prepaid Expenses	12.84	12.53	12.13
Restricted Cash	-	0.34	1.43
Total Current Assets	470.25	234.37	407.49
Property, Plant & Equipment	82.38	89.01	101.07
Other Long-Term Assets	9.06	6.81	9.7
Total Assets	561.69	330.18	518.26

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Accounts Payable	5.55	3.84	5.67
Accrued Expenses	22.78	39.54	19.34
Current Portion of Leases	13.62	15.01	16.72
Current Unearned Revenue	12.17	21.19	42.43
Other Current Liabilities	2.52	2.63	2.48
Total Current Liabilities	56.64	82.2	86.63
Long-Term Leases	49.01	53.52	60.26
Long-Term Unearned Revenue	-	4.51	15.17
Other Long-Term Liabilities	-	0.12	0.35
Total Liabilities	105.65	140.35	162.4

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Common Stock	0.13	0.05	0.05
Additional Paid-In Capital	1,261	60.17	38.45
Retained Earnings	-804.99	-676.29	-473.14
Comprehensive Income & Other	-0.13	0.11	0.12
Total Common Equity	456.05	-615.97	-434.52
Minority Interest	-	-7.23	-0.57
Shareholders' Equity	456.05	189.83	355.86
Total Liabilities & Equity	561.69	330.18	518.26

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Total Debt	62.63	68.53	76.97
Net Cash (Debt)	394.79	152.97	316.66
Net Cash Growth	-	-51.69%	-
Net Cash Per Share	4.81	3.05	6.50
Filing Date Shares Outstanding	128.35	50.3	49.66
Total Common Shares Outstanding	128.27	50.3	49.66
Working Capital	413.62	152.16	320.87
Book Value Per Share	3.56	-12.24	-8.75
Tangible Book Value	456.05	-615.97	-434.52
Tangible Book Value Per Share	3.56	-12.24	-8.75
Machinery	48	42.92	19.61
Construction In Progress	1.47	4.11	0.89
Leasehold Improvements	11.26	9.66	9.63

SEC Filings: 10-K · 10-Q